Carvedilol Post-intervention Long-term Administration in Large-scale Trial

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether beta-blocker therapy improves 6-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction and preserved left ventricular ejection fraction after primary percutaneous coronary intervention.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Takeshi Morimoto
• Treatments: Carvedilol

Criteria

Inclusion Criteria:

• Patients with STEMI after primary PCI

• Patients with left ventricular ejection fraction more than or equal to 40%

Exclusion Criteria:

• Patients with left ventricular ejection fraction less than 40%

• Patients with contraindication for beta-blocker

• Patients with implantable cardioverter defibrillators

• Patients with end-stage malignancy